← Back to Search

Device

Trocar Placement Assist Device (TPAD) for Laparoscopic Surgery

N/A
Waitlist Available
Led By James Lau, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 10 minutes
Awards & highlights

Study Summary

This trial assesses the safety and effectiveness of a new device that helps place a primary trocar during laparoscopic surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 10 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 10 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Surgeon satisfaction survey
Secondary outcome measures
Number of Participants with Treatment-Related Adverse Events as Assessed by CTCAE v4.0
Time required to obtain peritoneal access and place primary trocar during laparoscopic surgery

Trial Design

1Treatment groups
Experimental Treatment
Group I: Trocar Placement Assist Device (TPAD)Experimental Treatment1 Intervention
Participants will receive investigational TPAD device during laparoscopic surgery

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,393 Previous Clinical Trials
17,341,227 Total Patients Enrolled
TauTona GroupIndustry Sponsor
3 Previous Clinical Trials
82 Total Patients Enrolled
James LauLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots remaining for prospective participants in this research endeavor?

"This clinical trial, which was first posted on July 1st 2022, is no longer actively searching for patients. The last time it was edited was May 4th of the same year. Fortunately, there are 11 other trials currently recruiting participants."

Answered by AI
~3 spots leftby Apr 2025